Tuesday, April 19, 2022 3:29:21 PM
So true.
I gone over the past financials and I can't seem to see any significant bump with the announced "NEW CBD product line"
I read all the PR and can't find any proof that any of them were ever carried though.
They announce new pharmaceutical generic products but no new filings have been sent to the FDA.
Then there is the acquisition, no new news in 4 months, they must be doing that "cash basis " one sub penny at a time.
the company makes less than a local lawn service company.
I gone over the past financials and I can't seem to see any significant bump with the announced "NEW CBD product line"
I read all the PR and can't find any proof that any of them were ever carried though.
They announce new pharmaceutical generic products but no new filings have been sent to the FDA.
Then there is the acquisition, no new news in 4 months, they must be doing that "cash basis " one sub penny at a time.
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
